Malignant
mesothelioma is a rare form of cancer that affects the lung and chest
lining and/or the abdomen after prolonged exposure to asbestos. There
are three different kinds: pleural, peritoneal, or or pericardial
mesothelioma. The difference between the three is where the cancer is
located. Pleural mesothelioma victims have cancerous cells in the lungs,
pericardial mesothelioma patients have cancerous cells in the the
pericardium area of the heart, and peritoneal mesothelioma patients have
cancerous cells in the linings of the abdomen.
If you or a loved one suffer from an asbestos-related disease, you may qualify for substantial compensation. Currently, there is over $30 billion in asbestos trust funds, awaiting those who’ve been diagnosed with an asbestos illness. Use our free Asbestos Attorney Locator Tool today to find a leading mesothelioma attorney in your area.
Who is Affected?
As with other types of mesothelioma,
malignant mesothelioma typically affects people who have worked around
and have had prolonged exposure to asbestos, and although the ages will
vary, victims are typically males around 60 years of age.
However,
children and spouses exposed second-hand to asbestos run the risk of
developing the disease. For example, if a wife washes the clothes of her
husband who just spent the day working around asbestos, small asbestos
fibers may make their way into her lungs, causing the same damage as it
would to someone who worked around asbestos for years.
This type of asbestos exposure is rare, but it’s important to remember that anyone who has had any contact with asbestos runs the risk of getting this cancer.
Symptoms
As
aforementioned, the average age of malignant mesothelioma victims is
around 60. This stems from the fact that it usually takes 20 to 50 years
to properly diagnose the disease. As such, symptoms of mesothelioma usually don’t occur for decades after asbestos exposure and usually start out as if the victim is suffering from a common cold or the flu.
Typical symptoms include the following:
- Chest pain that starts out light and increases in severity over time
- Cough and hacking
- Fatigue and lethargy
- Shortness of breath
- Fever
As the disease progresses, the symptoms become more severe, including:
- Unusual weight loss
- Extreme bloating and abdominal pain
- Swelling in the arms and face
- Sweating profusely
- Difficulty in breathing and swallowing
- Chest pain becomes much more pronounced
Testing
When
testing for malignant mesothelioma, physicians will normally use chest
x-rays and a chest CT, along with a biopsy in order to remove fluids and
tissues in the lungs to check for asbestos fibers. Blood tests are also
administered and a thorough medical background and work history are
reviewed, including times you’ve been exposed to asbestos, will be
completed.
Per the American Cancer Society (ACS), when a chest
x-ray is performed, physicians look for unusual fluid buildup in the
lungs as well as any calcium deposits and changes in the shape of the
lungs. This is the first indication that the patient may have this
cancer, but other tests must be conducted before a final diagnosis is
made.
When performing a CT scan, physicians are able to gather a
more in-depth look at the lungs via cross-sectional images. This will
allow them to pinpoint and determine the exact location of the cancer.
Biopsies
are performed by inserting a long needle into the chest and directly
into the tumorous area. Physicians are then able to withdraw a sample of
the tumorous cells and analyze more thoroughly. If asbestos fibers are
found, a diagnosis of mesothelioma usually follows.
Treatments
Unfortunately,
there is no cure for malignant mesothelioma, and it is also one of the
most difficult forms of cancer to treat. If mesothelioma has moved into a
malignant stage, the disease is so advanced that in most cases, it’s
impossible to remove.
Therefore, surgery is usually not an option
as this stage unless the patient has a mass tumor. Even then, other
factors are taken into consideration such as the patient’s age and
overall health. This is not to say that all patients with malignant are
not candidates for surgery. Some people may still qualify for different
types of surgeries that aim to remove portions of the cancer as opposed
to the entire tumor.
If the patient does not qualify for surgery,
a combination of mesothelioma treatments can be used, such as
chemotherapy and radiation. This works by reducing the symptoms and
helping the victim live a better life with less pain.
Keep in
mind, however, that if left untreated, victims typically pass away
within nine months, according to the ACS. It’s imperative to follow up
with medical treatment and assistance even though there is no cure, as
it can help to prolong your life.
Your age, how long you were
exposed to asbestos, general health, and response to treatments will
also determine your survival rate. There is also no set rule to life
expectancy as each person’s medical history and health are unique. While
one person may survive up to a year, another person may go on to live
another decade or more.
Side Effects of Treatment
As with
anyone who undergoes surgery, chemotherapy, and radiation–regardless of
the disease–side effects typically follow. It’s important to remember,
however, that treatments affect different people in different way, and
not everyone will experience the same side effects.
The typical side effects from surgery, chemotherapy, and radiation are as follows:
- Hair thinning and hair loss
- Nausea with or without vomiting
- Easily prone to infections
- Bruising and bleeding easily
- Bladder changes–urinating more frequently or less frequently
- Body swelling
- Mouth ulcers
- Anemia
- Constipation and/or diarrhea
- Hard time remembering and concentrating
- Nerve damage
- Pain
Other
less common side effects include internal organ damage, hearing loss,
excessive bleeding, and blood clotting. All side effects typically stop
within a few months after treatment is complete. However, if you have a
high fever or just do not feel well, always consult with your physician
as soon as possible.